The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1159
ISSUE1159
June 23, 2003
Enfuvirtide (Fuzeon) for HIV infection
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Enfuvirtide (Fuzeon) for HIV infection
June 23, 2003 (Issue: 1159)
Enfuvirtide (T-20; Fuzeon Trimeris/Roche), the first in a new class of HIV drugs known as fusion inhibitors, has received accelerated approval from the FDA for use with other antiretrovirals in adults and children with viral replication despite...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.